HERBS AND BIOACTIVE COMPOUNDS IN PREVENTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA

35. Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T,Nakajima A, Hirohashi S: FOXP3+ regulatory T cells affect thedevelopment and progression of hepatocarcinogenesis. ClinCancer Res 2007, 13:902-911.36. Liu L, Chahroudi A, Silvestri G, Wernett ME, Kaiser WJ, Safrit JT,Kom[r]

Repeat transarterial chemoembolisation (rTACE) is often required for hepatocellular carcinoma (HCC) to achieve disease control, however, current practice guidelines regarding treatment allocation vary significantly.

field at the end of parenchymal transectionAs mentioned above, non-anatomical resections of segments 7, 8, and 1 havebeen usually excluded from laparoscopic approach because of difficult visualiza-tion of surgical field. Similarly right liver segmental anatomic resect[r]

The impact of sarcopenia on the prognosis of patients with hepatocellular carcinoma (HCC) who receive transcatheter intra-arterial therapies, including transcatheter arterial chemoembolization and transcatheter arterial infusion chemotherapy, remains unclear.

one of the most commonly usedmouthwash solutions identified instudies and has been used asprophylaxis for both chemotherapyand radiotherapy induced mucositis.However, the evidence does notsupport its use, indeed it has beensuggested that water mouthwashesare as effective as chlorhexidi[r]

Hepatocellular carcinoma (HCC) is the leading cause of cancer mortality. Chemical and virus induction are two major risk factors, however, the potential molecular mechanisms of their differences remain elusive.

Laparoscopic liver resection has been reported as a safe and effective approach for the management of hepatocellular carcinoma (HCC). However, its perioperative and oncological outcomes have not been evaluated in left hepatectomy patients. The aim of the present study is to compare the outcomes of l[r]

To determine the effect of Yttrium-90 (Y90) radioembolization on health-related quality of life (HRQOL) and its effect on overall survival advanced, unresectable infiltrative hepatocellular carcinoma (HCC) patients with concurrent portal vein thrombosis (PVT).

0.05). In cases of a suspected coccidiosisa t t a c k , A vera a n d A spicata were given toboth healthy and sick birds. The herbs weregiven to any type of chicken; however, themajority of the farmers used A l o e on theindigenous breeds (62.6%). The Aloe t[r]

has not been recommended within 10 days of surgery or parturi-tion [193] . Recommended treatment schedules vary, but all consist of an IV loading dose followed by continuous infusion for 12 – 72 hours, depending on the clinical situation [192] . Thrombolytic therapy is followed[r]

They demonstrated 100% ablation success with ablation times ranging from 15 to20 min in total, with initial 12-month follow-up demonstrating no evidence of abla-tion recurrence and a 50% hepatic non-ablation recurrence. These data have beenfurther strengthened by a collaborative[r]

Cancer 116:1938–194699. Haffner SM (2000) Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resis-tance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord 24(Suppl2):S56–S58100. Hautanen A (2000) Synthesis and regulation of sex hor[r]

Women with ductal carcinoma in situ (DCIS) report poor patient-clinician communication, and longlasting confusion and anxiety about their treatment and prognosis. Research shows that patient-centred care (PCC) improves patient experience and outcomes.

supplemented media is necessary. A multiplex polymerase chain reaction assay has been developed for simultaneous amplification of DNA targets from H. ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2. When this assay becomes commercially available, it will be a[r]

The majority of patients undergoing hepatectomy for hepatocellular carcinoma (HCC) suffer from underlying liver disease and are exposed to the risk of postoperative ascites, which is favored by an imbalance between portal venous inflow and a diminished hepatic volume.

SETDB1 promotes the metastasis of HCC cells in vitro and in vivo
Previous studies have confirmed that Tiam1 is essential to promote the invasion of HCC cells. Transwell and Boyden Chambers ’ assays prove that the penetration of cells increased in[r]

No consensus treatment has been reached for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial chemoembolization (TACE) have been recommended as effective options, but which is better remains unclear.

Currently, some studies have demonstrated that miR-34a could serve as a suppressor of several cancers including hepatocellular carcinoma (HCC). Previously, we discovered that miR-34a was downregulated in HCC and involved in the tumorigenesis and progression of HCC; however, the mechanism remains unc[r]